Cytotoxic agents for the treatment of cancer
US10881678B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 19, 2019 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Feb 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.